Declines in HIV incidence among men and women in a South African population-based cohort

• Published in: Nature communications 2019-12, Vol.10 (1), p.5482-10, Article 5482
• Main Authors: Vandormael, Alain, Akullian, Adam, Siedner, Mark, de Oliveira, Tulio, Bärnighausen, Till, Tanser, Frank
• Format: Article
• Language: English
• Subjects: 692/308/174; 692/699/255/1901; Adolescent; Adult; Anti-HIV Agents - therapeutic use; Antiretroviral agents; Antiretroviral therapy; Circumcision, Male; Cohort Studies; Female; HIV; HIV Infections - drug therapy; HIV Infections - epidemiology; Human immunodeficiency virus; Humanities and Social Sciences; Humans; Incidence; Infections; Male; Men; Middle Aged; multidisciplinary; Population; Science; Science (multidisciplinary); Seroconversion; South Africa - epidemiology; Women; Young Adult
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/s41467-019-13473-y

Over the past decade, there has been a massive scale-up of primary and secondary prevention services to reduce the population-wide incidence of HIV. However, the impact of these services on HIV incidence has not been demonstrated using a prospectively followed, population-based cohort from South Africa—the country with the world’s highest rate of new infections. To quantify HIV incidence trends in a hyperendemic population, we tested a cohort of 22,239 uninfected participants over 92,877 person-years of observation. We report a 43% decline in the overall incidence rate between 2012 and 2017, from 4.0 to 2.3 seroconversion events per 100 person-years. Men experienced an earlier and larger incidence decline than women (59% vs. 37% reduction), which is consistent with male circumcision scale-up and higher levels of female antiretroviral therapy coverage. Additional efforts are needed to get more men onto consistent, suppressive treatment so that new HIV infections can be reduced among women. Here, the authors investigate the outcome of prevention services scale-up on HIV incidence in a South African large population-based HIV surveillance cohort with over a decade of follow-up and associate a 43% reduction in incidence to earlier male medical circumcision and increased levels of antiretroviral therapy coverage.